Your search returned 6 results.

Results
	1.	Multidisciplinary Management of Locally Advanced Breast Cancer. [electronic resource] by Carlson, Robert W Favret, Anne M Publication details: The breast journal Sep 1999 In: The breast journal vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	HER2-positive advanced breast cancer. [electronic resource] by Robert, Nicholas J Favret, Anne M Producer: 20070720 In: Hematology/oncology clinics of North America vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices. [electronic resource] by Denduluri, Neelima Patt, Debra A Wang, Yunfei Bhor, Menaka Li, Xiaoyan Favret, Anne M Morrow, Phuong Khanh Barron, Richard L Asmar, Lina Saravanan, Shanmugapriya Li, Yanli Garcia, Jacob Lyman, Gary H Producer: 20160819 In: Journal of the National Comprehensive Cancer Network : JNCCN vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial. [electronic resource] by Sonke, Gabe S Hart, Lowell L Campone, Mario Erdkamp, Frans Janni, Wolfgang Verma, Sunil Villanueva, Cristian Jakobsen, Erik Alba, Emilio Wist, Erik Favret, Anne M Bachelot, Thomas Hegg, Roberto Wheatley-Price, Paul Souami, Farida Sutradhar, Santosh Miller, Michelle Germa, Caroline Burris, Howard A Producer: 20181024 In: Breast cancer research and treatment vol. 167 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study. [electronic resource] by Jones, Stephen E Collea, Rufus Paul, Devchand Sedlacek, Scot Favret, Anne M Gore, Ira Lindquist, Deborah L Holmes, Frankie Ann Allison, Mary Ann K Brooks, Barry D Portillo, Raul M Vukelja, Svetislava J Steinberg, Michael S Stokoe, Christopher Crockett, Maria W Wang, Yunfei Asmar, Lina Robert, Nicholas J O'Shaughnessy, Joyce Producer: 20131126 In: The Lancet. Oncology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer. [electronic resource] by Hortobagyi, Gabriel N Stemmer, Salomon M Burris, Howard A Yap, Yoon-Sim Sonke, Gabe S Paluch-Shimon, Shani Campone, Mario Blackwell, Kimberly L André, Fabrice Winer, Eric P Janni, Wolfgang Verma, Sunil Conte, Pierfranco Arteaga, Carlos L Cameron, David A Petrakova, Katarina Hart, Lowell L Villanueva, Cristian Chan, Arlene Jakobsen, Erik Nusch, Arnd Burdaeva, Olga Grischke, Eva-Maria Alba, Emilio Wist, Erik Marschner, Norbert Favret, Anne M Yardley, Denise Bachelot, Thomas Tseng, Ling-Ming Blau, Sibel Xuan, Fengjuan Souami, Farida Miller, Michelle Germa, Caroline Hirawat, Samit O'Shaughnessy, Joyce Producer: 20161213 In: The New England journal of medicine vol. 375 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)